contents

america
 

Drug Discovery & Development of Innovative Therapeutics Congress

Joseph B. Bolen, Ph.D., CSO of Millennium Pharmaceuticals, will chair the Focus on Cancer track IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics Conference and Exhibition taking place August 4-7 at the World Trade Center Boston & Seaport Hotel in Boston, MA. The cancer track presentations will focus on therapies for Hematology, Lung Cancer, Blood Borne Cancers, and Clinical Biomarkers. Drug Discovery & Development of Innovative Therapeutics World Congress is the industry's premier, international conference and exhibition to provide education on the most vital topics in drug discovery and development to help accelerate products to market.

Bolen has confirmed academia speakers including: Kenneth C. Anderson, M.D., Dana Farber Cancer Institute, Harvard Medical School; Bruce E. Johnson, M.D., Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital; Mark A. Israel, M.D., Dartmouth Medical School; Neal Rosen, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center; Massimo Loda, M.D., Dana Farber Cancer Institute, Brigham & Women's Hospital, Harvard Medical School

Companies also giving technical conference presentations in this cancer track include Alnylam Pharmaceuticals, Amgen, Inc., ARIAD Pharmaceuticals Inc., ArQule, Inc., AstraZeneca R&D Boston, Bristol-Myers Squibb Company, Exelixis Inc, Genzyme Corporation, Infinity Pharmaceuticals, Inc, Merck Research Laboratories, Novartis Institutes for BioMedical Research, OncoMed Pharmaceuticals Inc, The Johnson & Johnson Family of Companies.

Additional conference sessions at Drug Discovery & Development of Innovative Therapeutics conference include Cardio-Metabolic Disease Drug Discovery and Development; Translational Medicine/Research; Transforming Technologies; Anti-Infective Drug Discovery and Development; Neurodegenerative Disease Drug Discovery and Development; Inflammation in Drug Discovery and Development; Orphan Diseases: Fast-Tracking Orphan Drugs and Scientific Advances; The Next Generation of Therapeutics: Emerging Biologics, Stem Cells and RNAi.

The event provides a meeting place for attendees from around the world to network, find business and scientific partners and to discuss scientific advances, R&D strategies, business alliances and informatics solutions in drug discovery and development.



write your comments about the article :: 2008 Exhibition News :: home page